Severus Snape began as a dark, Slytherin-associated antagonist. Potter-heads from all over still wonder whether he actually ...

The infamous author has used the British Royal Family to draw inspiration for her characters. But Rowling's crown continues ...

An FDA approval has officially lifted the curtain on a blockbuster market showdown between Novartis and Eli Lilly in early breast cancer. The FDA has greenlighted Novartis’ Kisqali, used in ...

WIRED is where tomorrow is realized. It is the essential source of information and ideas that make sense of a world in constant transformation. The WIRED conversation illuminates how technology is ...

Lily Allen is in the doghouse with PETA after a recent revelation, but she's firing back. The "Smile" singer, 39, faced backlash on social media after revealing on the "Miss Me?" podcast that she ...

Eli Lilly has again upped the ante in scaling up its manufacturing footprint, this time revealing an investment totaling $1.8 billion to expand production capacity at two plants in Ireland.

Lily Allen is under fire for returning her “badly behaved dog.” The singer confessed to her “Miss Me?” podcast listeners Thursday that she took her puppy Mary back to an animal shelter.

Drugmaker Eli Lilly is significantly lowering the prices of the two lowest doses of its blockbuster weight loss drug Zepbound, it said Tuesday, in a move to expand access and ease supply constraints.

Magazine. Ammar Rowaid/Patrick McMullan via Getty Lily Allen shared that she returned a dog she adopted during the pandemic following an incident with her family's passports. In the Thursday ...

Lily Allen has revealed the sad reason she felt forced to get rid of her dog - after it caused disruption and ate their family's passports. singer was left distraught after the pooch turned their ...

Eli Lilly is announcing a new way to get its popular Zepbound drug. People who are in need of weight loss medications but do not have insurance coverage will soon have a new way to access one of ...

It’s here, roughly 10 minutes from town, that US pharmaceutical giant Eli Lilly & Co. is making its latest push to slake the unprecedented demand for its blockbuster drugs, Mounjaro and Zepbound.